NEO
Neogenomics·NASDAQ
--
--(--)
--
--(--)
5.47 / 10
Netural
The fund flow profile scores 7.37/10, demonstrating robust fund flow characteristics. Favorable overall, block, Small, Large, and Extra-large movements are tempered by challenging Medium dynamics, supporting positive flow assessment. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 3.58 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-12
InstitutionNeedham
Times predicted5
Historical Win Rate40.0%
What is the market sentiment for NEO?
- NEO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.47/10 (Netural).
